Selected Publications

  1. Santana-Magal N, Farhat-Younis L, Gutwillig A, Gleiberman A, Rasoulouniriana D, Tal L, et al. Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy. Cancer Res. 2020;80(10):1942-56

  2. D. Rasoulouniriana, N. Santana-Magal, A. Gutwillig, Y. Wine, C. Saperia, L. Farchat, Tal. L., H. Gutman, R. Brenner, P. Rider, Carmi Y. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. 2019, The Journal of Clinical Investigation 129(10):4151–4164.

  3. MH. Spitzer* and Y. Carmi*, NE. Reticker-Flynn, D. Madhireddy, PF. Gherardini, J. Chabon, GP. Nolan and EG. Engleman. Modeling effective cancer immunotherapy reveals the importance of systemic immunity. Cell. 2017. I

  4. Rider P. Carmi Y. Cohen I. 2016. Biologics for targeting inflammatory cytokines, clinical uses, and limitations. International Journal of Cell Biology Article ID 9259646

  5. Santana-Magal N., Rasoulouniriana D., Vladimirsky J., Rider P., Carmi Y. 2017. Isolation of monocyte-derived dendritic cells and their activation with tumor immune complexes. 2017. JoVE 

  6. Carmi Y., Prestwood TR., Spitzer M.H., Linde I.L., Chabon J., Reticker-Flynn N.E., Bhattacharya N., Zhang H., Zhang X., Basto P.A., Burt B.M., Alonso M.N., and Engleman. E.G. Akt and SHP1 are dendritic cell-intrinsic checkpoints for tumor immunity. 2016. JCI Insight. 3; 1(18): e89020

  7. Rider P* and Carmi Y*, Yossef R, Guttman O, Eini H, Azam T, Dinarello CA, Lewis EC. IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation. J Immunol. 2015 Aug 15;195(4):1705-12.   

  8. Carmi, Y., Spitzer, M.H., Linde, I.L., Burt, B.M., Prestwood, T.R., Perlman, N., Davidson, M.G., Kenkel, J.A., Segal, E., Pusapati, G.V., et al. 2015. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 521:99-104. (IF:41.45,  cited:19)

  9. Rider, P. and Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M.R., Dinarello, C.A., and Apte, R.N. 2011. IL-1a and IL-1b recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 187:4835-4843. 

Patents

  1. Carmi Y, Rider P. and Rasuluniriana D. T cell expressing an Fc gamma and a method thereof. 62/820,357
     

  2. Carmi Y, Rider P. and Rasuluniriana D. and Tal L. Multi subunit protein modules, cells expressing same and uses thereof  2020

2016 The Carmi Lab: Cancer Immunobiology and Immunotherapy

The Department of Pathology, School of Medicine, Tel-Aviv University,

P.O. Box 39040, Tel Aviv 6997801, Israel

  • LinkedIn Clean Grey

© 2020 by PhD Yaron Carmi

This site was designed with the
.com
website builder. Create your website today.
Start Now